Keyphrases
Acute Colitis
8%
Acute Phase Proteins
33%
Anti-inflammatory Molecules
8%
Antibacterial Activity
8%
Bacterial Siderophores
8%
Biologic Activity
25%
Biological Therapeutics
8%
Catalytic Iron
8%
Chelation
8%
Chronic Colitis
8%
Colitis
8%
Crohn's Colitis
8%
Dynamic Regulation
8%
Europe
8%
Extreme Events
8%
Gene-deficient Mice
8%
Gut Inflammation
8%
Host Cell Proteins
8%
Human Inflammatory Bowel Disease
16%
Inflammatory Bowel Disease
100%
Inflammatory Conditions
8%
Inflammatory Diseases
8%
Inflammatory Mediators
8%
Inflammatory Response
8%
Intestinal Inflammation
16%
Intestine
8%
Iron Homeostasis
8%
Iron Transport
8%
Lipocalin 2 (LCN2)
100%
Low Affinity
8%
Low-grade Inflammation
8%
LPS-induced Sepsis
8%
Mechanism of Action
8%
Murine Colitis
8%
Neutrophil Activation
8%
Novel Therapeutics
8%
Order of Magnitude
8%
Orthologs
8%
Post-translational Modification
8%
Sepsis
8%
Sequester
8%
Therapeutic Agents
8%
Therapeutic Potential
8%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
8%
Medicine and Dentistry
Acute Phase Protein
30%
Anti-Inflammatory Drug
7%
Antibacterial Activity
7%
Colitis
23%
Crohn's Disease
7%
Drive
15%
Enteritis
15%
Gut
23%
Homeostasis
7%
Inflammatory Bowel Disease
100%
Inflammatory Disorder
7%
Inflammatory Mediator
7%
Iron
23%
Iron Homeostasis
7%
Iron Transport
7%
Lipopolysaccharide-Induced Sepsis
7%
Neutrophil
7%
Neutrophil Gelatinase Associated Lipocalin
100%
Orthology
7%
Post-Translational Modification
7%
Sepsis
7%
Serositis
15%
Siderophore
7%
Therapeutic Agent
7%
Ulcerative Colitis
7%
Immunology and Microbiology
Acute Phase Protein
36%
Antibacterial Activity
9%
Chelation
9%
Colitis
27%
Crohn's Disease
9%
Enteritis
18%
Homeostasis
9%
Inflammation Response
9%
Inflammatory Bowel Disease
100%
Inflammatory Disorder
9%
Intestine
9%
Iron Homeostasis
9%
Iron Transport
9%
Lipocalin
9%
Lipocalin-2
100%
Mediator
9%
Microflora
9%
Neutrophil
18%
Orthology
9%
Post-Translational Modification
9%
Ulcerative Colitis
9%